Published in BMC Cancer on March 12, 2010
Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions. Cell Mol Life Sci (2012) 1.03
MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. PLoS One (2014) 0.99
Mitogen-activated protein kinase phosphatase-1 modulates regional effects of injurious mechanical ventilation in rodent lungs. Am J Respir Crit Care Med (2012) 0.83
Synergistic signaling of tumor cell invasiveness by hepatocyte growth factor and hypoxia. J Biol Chem (2014) 0.80
Identification of TNM stage-specific genes in lung adenocarcinoma by genome-wide expression profiling. Oncol Lett (2013) 0.79
DUSP1 phosphatase regulates the proinflammatory milieu in head and neck squamous cell carcinoma. Cancer Res (2014) 0.76
Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression. Oncotarget (2016) 0.76
Identification and Characterisation of a Novel Protein FIP-sch3 from Stachybotrys chartarum. PLoS One (2016) 0.75
Repression of breast cancer cell growth by proteasome inhibitors in vitro: impact of mitogen-activated protein kinase phosphatase 1. Cancer Biol Ther (2015) 0.75
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer (2007) 14.84
Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer (2003) 13.01
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol (2005) 9.95
Mitogen-activated protein kinases in apoptosis regulation. Oncogene (2004) 4.76
Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell (1998) 3.71
JNK phosphorylates paxillin and regulates cell migration. Nature (2003) 3.60
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci U S A (1998) 3.46
Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncol (2007) 3.39
Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev (2006) 3.30
ERK implication in cell cycle regulation. Biochim Biophys Acta (2006) 2.96
From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life (2005) 2.79
Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev (2008) 2.75
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest (2002) 2.31
K-ras mutations in non-small-cell lung carcinoma: a review. Clin Lung Cancer (2006) 2.29
Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta (2007) 2.11
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol (2004) 2.08
Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation. Cancer Res (2001) 1.96
Selective p38 activation in human non-small cell lung cancer. Am J Respir Cell Mol Biol (2002) 1.75
Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene (1998) 1.69
Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol Cell Biol (2001) 1.68
Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer. Oncogene (2004) 1.50
Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. Am J Pathol (2001) 1.48
Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. Cancer Lett (2003) 1.39
Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol (1996) 1.37
The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase. J Biol Chem (1996) 1.36
Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance. Cancer Res (2006) 1.35
CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cell Signal (2006) 1.29
Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Clin Cancer Res (2004) 1.24
alpha 2 integrin subunit cytoplasmic domain-dependent cellular migration requires p38 MAPK. J Biol Chem (2000) 1.22
Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma. Int J Cancer (2002) 1.18
Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells. Clin Cancer Res (2004) 1.16
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3. BMC Cancer (2008) 1.14
Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer. Prostate (2003) 1.12
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin. Clin Cancer Res (2008) 1.09
CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. Carcinogenesis (2008) 1.08
Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells. Exp Mol Med (2005) 1.02
PPARgamma and MEK Interactions in Cancer. PPAR Res (2008) 1.02
Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells. Biochem Pharmacol (2007) 1.01
An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells. Clin Exp Metastasis (2002) 0.97
Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade. Lung Cancer (2002) 0.96
Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis. Mol Cell Biochem (1999) 0.93
CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential. Oncogene (2002) 0.93
Suppressed MKP-1 is an independent predictor of outcome in patients with hepatocellular carcinoma. Oncology (2005) 0.92
c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas. Am J Pathol (2007) 0.91
The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines. Expert Opin Ther Targets (2007) 0.91
Rosiglitazone attenuates NF-kappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1/2/p38MAPK activation. Biochem Biophys Res Commun (2007) 0.83
Non-small cell lung cancer: new hope for a chronic illness. Oncol Nurs Forum (2007) 0.78
Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res (2010) 3.18
Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia (2005) 2.04
EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res (2010) 1.95
Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res (2005) 1.86
Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan. PLoS One (2012) 1.53
Concern Dual regeneration of muscle and nerve by intravenous administration of human amniotic fluid-derived mesenchymal stem cells regulated by stromal cell-derived factor-1α in a sciatic nerve injury model. J Neurosurg (2012) 1.51
Dyspareunia and its comorbidities among Taiwanese women: analysis of the 2004-2010 Nationwide Health Insurance Database. J Sex Med (2015) 1.41
Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells (2005) 1.39
Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res (2010) 1.39
Antitumor and antimetastatic activity of IL-23. J Immunol (2003) 1.38
Intense uptake of [F-18]-fluoro-2 deoxy-D-glucose in active pulmonary tuberculosis. Ann Nucl Med (2003) 1.32
Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res (2003) 1.21
Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol (2006) 1.20
A mouse model of blast-induced mild traumatic brain injury. Exp Neurol (2011) 1.20
CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells. Int J Cancer (2005) 1.18
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem (2002) 1.18
HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. EMBO J (2004) 1.17
Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res (2005) 1.17
Curcumin provides neuroprotection after spinal cord injury. J Surg Res (2009) 1.16
Household out-of-pocket medical expenditures and National Health Insurance in Taiwan: income and regional inequality. BMC Health Serv Res (2005) 1.16
Urbanization and stroke prevalence in Taiwan: analysis of a nationwide survey. J Urban Health (2007) 1.16
Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-rich plasma. Biomaterials (2009) 1.14
Nitric oxide from both exogenous and endogenous sources activates mitochondria-dependent events and induces insults to human chondrocytes. J Cell Biochem (2007) 1.13
In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes. Arthritis Rheum (2009) 1.13
Using health smart cards to check drug allergy history: the perspective from Taiwan's experiences. J Med Syst (2009) 1.12
Resonance frequency assessment of dental implant stability with various bone qualities: a numerical approach. Clin Oral Implants Res (2002) 1.11
hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J Clin Invest (2010) 1.11
MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells. Arch Toxicol (2012) 1.10
Burnout, job satisfaction, and medical malpractice among physicians. Int J Med Sci (2013) 1.09
Comparisons of the brief form of the World Health Organization Quality of Life and Short Form-36 for persons with spinal cord injuries. Am J Phys Med Rehabil (2007) 1.09
Risk of epilepsy after traumatic brain injury: a retrospective population-based cohort study. J Neurol Neurosurg Psychiatry (2012) 1.08
The balance between adipogenesis and osteogenesis in bone regeneration by platelet-rich plasma for age-related osteoporosis. Biomaterials (2011) 1.06
Targeting cancer stem cells: emerging role of Nanog transcription factor. Onco Targets Ther (2013) 1.06
Role of angiogenic and non-angiogenic mechanisms in oral squamous cell carcinoma: correlation with histologic differentiation and tumor progression. J Oral Pathol Med (2004) 1.06
The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer. Stem Cells (2013) 1.05
Zerumbone suppresses IKKα, Akt, and FOXO1 activation, resulting in apoptosis of GBM 8401 cells. J Biomed Sci (2012) 1.04
MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiation. J Biol Chem (2009) 1.03
Effectiveness of different types of motorcycle helmets and effects of their improper use on head injuries. Int J Epidemiol (2011) 1.03
Early detection of implant healing process using resonance frequency analysis. Clin Oral Implants Res (2003) 1.03
Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. J Biomed Sci (2005) 1.02
Attenuating experimental spinal cord injury by hyperbaric oxygen: stimulating production of vasculoendothelial and glial cell line-derived neurotrophic growth factors and interleukin-10. J Neurotrauma (2010) 1.02
Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology (2005) 1.02
Regression analysis for the sorption isotherms of basic dyes on sugarcane dust. Bioresour Technol (2005) 1.01
Inhibition of Nodal suppresses angiogenesis and growth of human gliomas. J Neurooncol (2010) 1.01
Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials (2011) 1.01
Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction. Circulation (2002) 1.00
Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season. PLoS One (2013) 1.00
Osteopontin regulates human glioma cell invasiveness and tumor growth in mice. Neuro Oncol (2009) 1.00
Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis (2004) 1.00
Hirayama disease. J Neurosurg Spine (2010) 0.99
Autophagy is activated in injured neurons and inhibited by methylprednisolone after experimental spinal cord injury. Spine (Phila Pa 1976) (2012) 0.98
Two non-homologous brain diseases-related genes, SERPINI1 and PDCD10, are tightly linked by an asymmetric bidirectional promoter in an evolutionarily conserved manner. BMC Mol Biol (2007) 0.98
Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways. Cell Signal (2005) 0.98
The significance of FDG uptake in bilateral thyroid glands. Nucl Med Commun (2007) 0.97
Human cytomegalovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication. J Virol (2004) 0.97
Multifaceted effects of rapamycin on functional recovery after spinal cord injury in rats through autophagy promotion, anti-inflammation, and neuroprotection. J Surg Res (2012) 0.97
Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx. J Nucl Med (2007) 0.96
Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram. Mol Pharmacol (2003) 0.96
Prevention and repair of circulatory shock and cerebral ischemia/injury by various agents in experimental heatstroke. Curr Med Chem (2006) 0.96
Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells. J Cereb Blood Flow Metab (2010) 0.95
Comparison of tongue functions between mature and tongue-thrust swallowing--an ultrasound investigation. Am J Orthod Dentofacial Orthop (2004) 0.95
Risk of musculoskeletal disorder among Taiwanese nurses cohort: a nationwide population-based study. BMC Musculoskelet Disord (2013) 0.94
Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression. Biochem Biophys Res Commun (2003) 0.94
Repeated ovarian stimulations induce oxidative damage and mitochondrial DNA mutations in mouse ovaries. Ann N Y Acad Sci (2005) 0.94
Rac1 regulates peptidoglycan-induced nuclear factor-kappaB activation and cyclooxygenase-2 expression in RAW 264.7 macrophages by activating the phosphatidylinositol 3-kinase/Akt pathway. Mol Immunol (2008) 0.94
Congenital midline nasal mass: cases series and review of the literature. Turk J Pediatr (2011) 0.93
Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2. Tumour Biol (2014) 0.93
Mass screening of suspected febrile patients with remote-sensing infrared thermography: alarm temperature and optimal distance. J Formos Med Assoc (2008) 0.92
Evaluation of loading conditions on fatigue-failed implants by fracture surface analysis. Int J Oral Maxillofac Implants (2006) 0.92
Gene transfer of insulin-like growth factor-I providing neuroprotection after spinal cord injury in rats. J Neurosurg Spine (2007) 0.92
Lifelong reporter gene imaging in the lungs of mice following polyethyleneimine-mediated sleeping-beauty transposon delivery. Biomaterials (2010) 0.91
Working memory in patients with mild traumatic brain injury: functional MR imaging analysis. Radiology (2012) 0.91
Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas. J Neurooncol (2010) 0.90
Molecular mechanism of nitric oxide-induced osteoblast apoptosis. J Orthop Res (2005) 0.90
Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW 264.7 cells. J Ethnopharmacol (2007) 0.90
Tanshinone IIA from Salvia miltiorrhiza induces heme oxygenase-1 expression and inhibits lipopolysaccharide-induced nitric oxide expression in RAW 264.7 cells. Mitochondrion (2006) 0.90
Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect. Cancer Res (2012) 0.90
Correlation between Glasgow coma score components and survival in patients with traumatic brain injury. Injury (2010) 0.90
Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. J Nucl Med (2006) 0.90
Suppression of the invasion and migration of cancer cells by SERPINB family genes and their derived peptides. Oncol Rep (2011) 0.89
The immediate early 2 protein of human cytomegalovirus (HCMV) mediates the apoptotic control in HCMV retinitis through up-regulation of the cellular FLICE-inhibitory protein expression. J Immunol (2006) 0.89
The effectiveness of video-telemedicine for screening of patients requesting emergency air medical transport (EAMT). J Trauma (2007) 0.89
A Preclinical Evaluation of Antrodia camphorata Alcohol Extracts in the Treatment of Non-Small Cell Lung Cancer Using Non-Invasive Molecular Imaging. Evid Based Complement Alternat Med (2011) 0.88
Improvement of ventilator-induced lung injury by IPS cell-derived conditioned medium via inhibition of PI3K/Akt pathway and IP-10-dependent paracrine regulation. Biomaterials (2012) 0.88
Risk and outcomes for traumatic brain injury in patients with mental disorders. J Neurol Neurosurg Psychiatry (2012) 0.88
c-Myc regulates the coordinated transcription of brain disease-related PDCD10-SERPINI1 bidirectional gene pair. Mol Cell Neurosci (2009) 0.88
Reduced use of emergency care and hospitalization in patients with traumatic brain injury receiving acupuncture treatment. Evid Based Complement Alternat Med (2013) 0.88
Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide-activated macrophages. J Trauma (2003) 0.88